Funding · Company
Attralus, Inc.
South San Francisco, CABiotech & Pharma
Attralus, Inc. of South San Francisco, CA has disclosed $173M across 2 Form D offerings filed with the SEC between Sep 24, 2021 and Feb 9, 2024.
$173M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001797582Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →